000 01483 a2200445 4500
005 20250517125247.0
264 0 _c20170517
008 201705s 0 0 eng d
022 _a1365-2710
024 7 _a10.1111/jcpt.12482
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOzbayer, C
245 0 0 _aEffects of genetic variations in the genes encoding NOD1 and NOD2 on type 2 diabetes mellitus and insulin resistance.
_h[electronic resource]
260 _bJournal of clinical pharmacy and therapeutics
_cFeb 2017
300 _a98-102 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlleles
650 0 4 _aDiabetes Mellitus, Type 2
_xgenetics
650 0 4 _aFemale
650 0 4 _aGenetic Predisposition to Disease
_xgenetics
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aInflammation
_xgenetics
650 0 4 _aInsulin Resistance
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMutation
_xgenetics
650 0 4 _aNod1 Signaling Adaptor Protein
_xgenetics
650 0 4 _aNod2 Signaling Adaptor Protein
_xgenetics
650 0 4 _aObesity
_xgenetics
650 0 4 _aRisk
650 0 4 _aTurkey
700 1 _aKurt, H
700 1 _aKebapci, M N
700 1 _aGunes, H V
700 1 _aColak, E
700 1 _aDegirmenci, I
773 0 _tJournal of clinical pharmacy and therapeutics
_gvol. 42
_gno. 1
_gp. 98-102
856 4 0 _uhttps://doi.org/10.1111/jcpt.12482
_zAvailable from publisher's website
999 _c26638815
_d26638815